Direct Switch from Sertraline 100 mg to Citalopram
You can directly switch from sertraline 100 mg daily to citalopram 20 mg daily without a taper or washout period, starting citalopram the day after stopping sertraline. Both are short-acting SSRIs with similar half-lives, making an immediate switch safe and practical 1, 2, 3.
Switching Strategy
Start citalopram 20 mg once daily (morning or evening) the day after the last dose of sertraline 100 mg 2. This direct switch approach is supported by:
- Both sertraline and citalopram are shorter-acting SSRIs that can be titrated at 1-2 week intervals 1
- No washout period is required when switching between non-MAOI SSRIs 1
- Direct switching from fluoxetine to citalopram has been demonstrated as safe and well-tolerated 3
- The risk of serotonin syndrome when switching between SSRIs (without MAOIs) is minimal if you start the second SSRI at a low dose 1
Dosing Considerations
Maximum dose of citalopram is 40 mg/day for most patients, but only 20 mg/day for:
- Patients >60 years of age
- Patients with hepatic impairment
- CYP2C19 poor metabolizers
- Patients taking cimetidine or other CYP2C19 inhibitors 2
Critical warning: Citalopram causes QT prolongation at doses >40 mg/day, associated with Torsades de Pointes, ventricular tachycardia, and sudden death 1. Screen for:
- Long QT syndrome history
- Concomitant QT-prolonging medications
- Cardiac risk factors in elderly patients 4
Monitoring Protocol
Monitor closely in the first 24-48 hours after the switch for serotonin syndrome symptoms 1:
- Mental status changes (confusion, agitation, anxiety)
- Neuromuscular hyperactivity (tremors, clonus, hyperreflexia)
- Autonomic hyperactivity (hypertension, tachycardia, diaphoresis)
Follow-up contact (in-person or telephone) within the first week to assess 5:
- Tolerability and adherence
- Emergence of adverse events
- Depressive symptom status
- Suicidal ideation (especially in adolescents/young adults)
Expected Outcomes
Response rates to a second SSRI after sertraline failure are modest:
- Approximately 47% response rate when switching to another SSRI 6, 7
- About 21% remission rate with second-step SSRI switch 8
- Most responses occur within 6 weeks, but full trial requires 12 weeks 8
Early response predictor: If the patient achieves ≥20% symptom reduction by week 2, they are 6 times more likely to ultimately respond or remit 8.
Discontinuation Syndrome Risk
Sertraline is associated with discontinuation syndrome (though less than paroxetine) 1. However, the immediate switch to citalopram provides serotonergic coverage that typically prevents withdrawal symptoms. Symptoms to watch for include:
- Dizziness, vertigo, imbalance
- Nausea, diarrhea
- Headaches, myalgias
- Anxiety, irritability, sensory disturbances
Drug Interaction Advantages
Citalopram has the least effect on CYP450 enzymes compared to other SSRIs, including sertraline 1. This makes it advantageous for patients on multiple medications, as it has lower propensity for drug-drug interactions than sertraline (which affects CYP2D6) 1.
Common Pitfalls to Avoid
- Do not exceed 40 mg/day citalopram (20 mg/day in elderly >60 years) due to cardiac risk 2
- Do not use a washout period between these two SSRIs—it's unnecessary and may worsen symptoms
- Do not start at higher doses thinking it will work faster—this increases adverse events without improving efficacy 1
- Do not combine with MAOIs—requires 14-day washout 2